← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2014Last known activity
Nov 1, 2016
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT02908802Lead sponsorN/ANov 1, 2016
- NCT02756221Reponsible party - principal investigatorN/AMar 1, 2016
- NCT02756221Lead sponsorN/AMar 1, 2016
- NCT02751840Lead sponsorPhase 3Oct 1, 2014
Details
- Last known activity
- Nov 1, 2016